Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 9, Number 7, 2003

Book Reviews

Preface
pp. i-i(1)
Author: Botta, M.

Favourites:
ADD

Review article

Regulation of Angiogenesis by Th1- and Th2-Type Cytokines
pp. 511-519(9)
Authors: Naldini, A.; Pucci, A.; Bernini, C.; Carraro, F.

Favourites:
ADD

Role of Nitric Oxide in the Modulation of Angiogenesis
pp. 521-530(10)
Authors: Morbidelli, L.; Donnini, S.; Ziche, M.

Favourites:
ADD

Protein kinases and the Hypoxia-Inducible Factor-1, two switches in angiogenesis
pp. 531-541(11)
Authors: Mazure, N.M.; Brahimi-Horn, M.C.; Pouyssgur, J.

Favourites:
ADD

Calcium as a Molecular Target in Angiogenesis
pp. 543-551(9)
Authors: Patton, A.M.; Kassis, J.; Doong, H.; Kohn, E.C.

Favourites:
ADD

Heparin Derivatives as Angiogenesis Inhibitors
pp. 553-566(14)
Authors: Presta, M.; Leali, D.; Stabile, H.; Ronca, R.; Camozzi, M.; Coco, L.; Moroni, E.; Liekens, S.; Rusnati, M.

Favourites:
ADD
Favourites:
ADD

Thrombospondins as Anti-Angiogenic Therapeutic Agents
pp. 583-588(6)
Authors: Vailh, B.; Feige, J-J.

Favourites:
ADD

Human Tissue Kallikrein: A New Bullet for the Treatment of Ischemia
pp. 589-597(9)
Authors: Emanueli, C.; Madeddu, P.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content